Home » Topics » BioWorld Science

BioWorld Science
RSS

Corat gains clearances to begin phase Ib/II trial of COR-101 for COVID-19

March 17, 2021

Phase Ib data with VS-01 support advancement to phase IIa for acute on chronic liver failure

March 17, 2021

French clearance for first-in-human study of PEP-010 in advanced solid tumors

March 17, 2021

THCVHS shows no signs of eye irritation in in vitro assay

March 17, 2021

Study reveals dose finding for gevokizumab in oncology

March 17, 2021

Biohaven Therapeutics identifies compounds targeting TDP-43

March 17, 2021

First-in-human results presented for R-552 in healthy adults

March 17, 2021

New anti-SIRP-alpha antibodies described by Elpiscience BioPharma

March 17, 2021

Otsuka Pharmaceutical, Taiho Pharmaceutical patent PTPN11 inhibitors

March 17, 2021

KalVista Pharmaceuticals discovers FXIIa inhibitors

March 17, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...